Treatment strategies for human brucellosis
10.3760/cma.j.cn231583-20220928-00330
- VernacularTitle:人间布鲁氏菌病的治疗策略
- Author:
Libo DAI
1
;
Haitao DING
;
Hongxin YANG
;
Wenyan LI
;
Zhanguo WANG
Author Information
1. 内蒙古自治区人民医院药学处，呼和浩特 010017
- Keywords:
Brucellosis;
Antibiotic therapy;
Treatment strategies;
Antibacterials
- From:
Chinese Journal of Endemiology
2024;43(2):152-156
- CountryChina
- Language:Chinese
-
Abstract:
Brucellosis is a zoonotic infectious disease caused by Brucella infection. So far, animal to animal Brucellosis has not been eradicated, and there is a lack of safe and effective human vaccine. Therefore, "early, combined, sufficient, and full course" drug treatment remains an important strategy in the management of human Brucellosis. The goal of treating brucellosis is to alleviate and shorten the symptom period, reduce complications, relapses, and chronicity. At present, although antibiotic treatment is effective for most patients, there are still some patients who experience treatment failure or later recurrence, so the treatment strategy for brucellosis urgently needs to be optimized. This article elaborates on the treatment principles, clinical treatment status, and future development trends of brucellosis, in order to provide references for optimizing drug treatment methods for brucellosis.
